A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy
- Authors
- Jung, Yoon Suk; Park, Chan Hyuk; Kim, Nam Hee; Park, Jung Ho; Park, Dong Il; Il Sohn, Chong
- Issue Date
- Mar-2018
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- Advanced colorectal neoplasia; Asia-Pacific Colorectal Screening; Colorectal cancer; Fecal immunochemical test; Screening
- Citation
- DIGESTIVE AND LIVER DISEASE, v.50, no.3, pp.254 - 259
- Indexed
- SCIE
SCOPUS
- Journal Title
- DIGESTIVE AND LIVER DISEASE
- Volume
- 50
- Number
- 3
- Start Page
- 254
- End Page
- 259
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/3163
- DOI
- 10.1016/j.dld.2017.11.002
- ISSN
- 1590-8658
- Abstract
- Background
We aimed to develop a combination screening strategy for advanced colorectal neoplasia based on the Asia-Pacific Colorectal Screening score and fecal immunochemical test results.
Methods
We reviewed the records of participants who had undergone a colonoscopy and fecal immunochemical test as part of a comprehensive health screening program. The prevalence of advanced colorectal neoplasia in participants 40–49 years old was analyzed according to Asia-Pacific Colorectal Screening scores and fecal immunochemical test results.
Results
We analyzed the data of 9205 participants 40–49 years old and 3215 participants ≥50 years old. The prevalence of advanced colorectal neoplasia in participants 40–49 years old was 1.0%, 2.1%, 7.1%, and 13.4% in the “fecal immunochemical test (−) & Asia-Pacific Colorectal Screening < 2,” “fecal immunochemical test (−) & Asia-Pacific Colorectal Screening ≥ 2,” “fecal immunochemical test (+) & Asia-Pacific Colorectal Screening < 2,” and “fecal immunochemical test (+) & Asia-Pacific Colorectal Screening ≥ 2” subgroups, respectively. The prevalence of advanced colorectal neoplasia in “fecal immunochemical test (+) & Asia-Pacific Colorectal Screening ≥ 2” subgroup was higher than in participants ≥50 years old with Asia-Pacific Colorectal Screening ≥ 4 (13.4% vs. 5.8%, P < 0.001).
Conclusions
Fecal immunochemical test-positive individuals 40–49 years old with an Asia-Pacific Colorectal Screening ≥ 2 have a higher risk of advanced colorectal neoplasia than individuals ≥50 years old with an Asia-Pacific Colorectal Screening ≥ 4.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/3163)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.